Format

Send to

Choose Destination
See comment in PubMed Commons below
Intern Med. 2008;47(13):1165-70. Epub 2008 Jul 1.

Ezetimibe, a selective inhibitor of the transport of cholesterol.

Author information

1
Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.

Abstract

Niemann-Pick C1-like 1 (NPC1L1) has recently been identified and has been shown to have features of a plasma membrane transporter, including a secretion signal, 13 predicted transmembrane domains, extensive N-linked glycosylation sites and a sterol-sensing domain. It is highly expressed on the surface of absorptive jejunal enterocytes. NPC1L1 has been shown to be a direct target of ezetimibe, and an ezetimibe-sensitive pathway plays a role in intestinal cholesterol absorption. Ezetimibe-based therapy represents an exciting new area in the treatment of dyslipidemia.

PMID:
18591835
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for J-STAGE, Japan Science and Technology Information Aggregator, Electronic
    Loading ...
    Support Center